Skip to main content

Artificial Intelligence Models Improve Clinicians' Diagnostic Accuracy

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 19, 2023.

By Elana Gotkine HealthDay Reporter

TUESDAY, Dec. 19, 2023 -- Standard artificial intelligence (AI) models improve diagnostic accuracy, but systematically biased AI models reduce this accuracy, according to a study published in the Dec. 19 issue of the Journal of the American Medical Association.

Sarah Jabbour, from the University of Michigan in Ann Arbor, and colleagues examined the impact of systematically biased AI on clinician diagnostic accuracy in a randomized clinical vignette survey study. Clinicians were shown nine clinical vignettes of patients hospitalized with acute respiratory failure and were asked to determine the likelihood of pneumonia, heart failure, or chronic obstructive pulmonary disease as the underlying cause. Clinicians were shown two vignettes without AI model input to establish baseline diagnostic accuracy and were then randomly assigned to see six vignettes with AI model input: three standard-model predictions and three systematically biased model predictions.

Overall, 457 clinicians were randomly assigned: 231 and 226 to AI model predictions without and with explanations, respectively. The researchers found that for the three diagnoses, clinicians' baseline diagnostic accuracy was 73.0 percent. Clinician accuracy increased over baseline by 2.9 and 4.4 percentage points when shown a standard AI model without and with explanations. Clinician accuracy was reduced by 11.3 percentage points with systematically biased AI model predictions compared with baseline; providing biased AI model predictions with explanations reduced accuracy by 9.1 percentage points, representing a nonsignificant improvement of 2.3 percentage points compared with the systematically biased model.

"Although the findings of the study suggest that clinicians may not be able to serve as a backstop against flawed AI, they can play an essential role in understanding AI's limitations," the authors write.

One author reported receiving royalties from a patent from Airstrip.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

Read this next

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

American College of Surgeons, Oct. 19-22

The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.